A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors
Clinical trial NCT05298592 · COMPLETED
Trial details
- NCT number
- NCT05298592
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-31
- Primary completion
- 2024-08-16
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.